Log in

NYSE:BAXBaxter International Stock Price, Forecast & News

$89.19
+0.56 (+0.63 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$88.18
Now: $89.19
$89.89
50-Day Range
$85.51
MA: $89.07
$94.14
52-Week Range
$69.10
Now: $89.19
$95.19
Volume2.84 million shs
Average Volume3.15 million shs
Market Capitalization$45.24 billion
P/E Ratio26.95
Dividend Yield0.99%
Beta0.83
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Read More
Baxter International logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.7Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.13 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.36 billion
Cash Flow$4.90 per share
Book Value$15.50 per share

Profitability

Net Income$1.00 billion

Miscellaneous

Employees50,000
Market Cap$45.24 billion
Next Earnings Date7/23/2020 (Estimated)
OptionableOptionable

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

Baxter International (NYSE:BAX) Frequently Asked Questions

How has Baxter International's stock been impacted by COVID-19 (Coronavirus)?

Baxter International's stock was trading at $77.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BAX shares have increased by 14.4% and is now trading at $89.19. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Baxter International?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Baxter International.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for Baxter International.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) released its quarterly earnings results on Thursday, April, 30th. The medical instruments supplier reported $0.82 earnings per share for the quarter, beating analysts' consensus estimates of $0.73 by $0.09. The medical instruments supplier earned $2.80 billion during the quarter, compared to analysts' expectations of $2.74 billion. Baxter International had a net margin of 8.85% and a return on equity of 22.70%. The firm's revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.76 earnings per share. View Baxter International's earnings history.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, May 5th. Investors of record on Friday, June 5th will be given a dividend of $0.245 per share on Wednesday, July 1st. This represents a $0.98 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Thursday, June 4th. This is a positive change from Baxter International's previous quarterly dividend of $0.22. View Baxter International's dividend history.

How will Baxter International's stock buyback program work?

Baxter International announced that its Board of Directors has approved a share repurchase program on Tuesday, November 13th 2018, which permits the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 6.1% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's management believes its stock is undervalued.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its first quarter earnings guidance on Tuesday, March, 17th. The company provided earnings per share (EPS) guidance of $0.72-0.74 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.81.

What price target have analysts set for BAX?

19 brokers have issued 1 year target prices for Baxter International's stock. Their forecasts range from $84.00 to $105.00. On average, they anticipate Baxter International's stock price to reach $96.42 in the next year. This suggests a possible upside of 8.1% from the stock's current price. View analysts' price targets for Baxter International.

Has Baxter International been receiving favorable news coverage?

Media headlines about BAX stock have been trending extremely negative this week, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Baxter International earned a coverage optimism score of -5.0 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news aboutBaxter International.

Are investors shorting Baxter International?

Baxter International saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 5,570,000 shares, a drop of 14.6% from the April 30th total of 6,520,000 shares. Based on an average daily volume of 3,330,000 shares, the short-interest ratio is presently 1.7 days. Approximately 1.1% of the company's stock are short sold. View Baxter International's Current Options Chain.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Honeywell International (HON), Cisco Systems (CSCO), AT&T (T), Pfizer (PFE), BlackRock (BLK), Verizon Communications (VZ), Abbott Laboratories (ABT) and Procter & Gamble (PG).

Who are Baxter International's key executives?

Baxter International's management team includes the following people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 53)

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.14%), Wellington Management Group LLP (5.90%), State Street Corp (4.63%), Morgan Stanley (3.83%), Third Point LLC (2.28%) and Veritas Asset Management LLP (1.76%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Sean Martin, Third Point Llc and Thomas T Stallkamp. View institutional ownership trends for Baxter International.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Wellington Management Group LLP, Eaton Vance Management, First Trust Advisors LP, Mackenzie Financial Corp, Prudential PLC, AQR Capital Management LLC, and Skandinaviska Enskilda Banken AB publ. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, and John D Forsyth. View insider buying and selling activity for Baxter International.

Which major investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Capital International Investors, Veritas Asset Management LLP, Morgan Stanley, Bessemer Group Inc., Nuveen Asset Management LLC, Caisse DE Depot ET Placement DU Quebec, and Sumitomo Mitsui Trust Holdings Inc.. View insider buying and selling activity for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $89.19.

How big of a company is Baxter International?

Baxter International has a market capitalization of $45.24 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.

What is Baxter International's official website?

The official website for Baxter International is www.baxter.com.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.